We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
NeuroVision is developing and studying an experimental, breakthrough, low-cost, noninvasive, eye-imaging system for measuring autofluorescence, which can detect amyloid beta (Aβ) plaque in the eye. Aβ plaque deposits
By incorporating VAMS specimen collection and transportation technology into its CleanAssure clinical convenience kits and testing menu, Alcala Labs is the first to commercialize an offering to addiction
Medical Precision BV was established by Annelies Maas-Kortenhorst and Roland Kortenhorst and is located in Zwolle, Netherlands. CIVCO Radiotherapy will be the exclusive worldwide distributor of this unique
The Surpass Streamline device is the second flow diverting stent to secure FDA approval in the U.S. It is also approved and available in several markets globally. The
Situated in Brescia, Italy, Open Technologies provides portfolio of compact, 3D structured light scanning solutions that specifically allow dentists, dental technicians and orthopedics to use the 3D world
The microtip partnership assay (MPA) program helps Ortho in validating and in offering high value, esoteric testing, in step with the evolving needs of today’s labs. The assays
This device is expected to give health officials time to take action before the viruses are transmitted to humans. SMK Diagnostics has created biosensor technology to identify and
The funding will accelerate the development and regulatory validation of an over-the-counter and professional use Influenza and Multiplex Respiratory Pathogen diagnostic cartridges for the Cue Health Monitoring System.
The company said that its initial clinical evaluation of the prevascularized Cell Pouch showed biocompatibility and safety of the Cell Pouch along with viability and vascularization of its
The assay will provide a quantitative technique to evaluate RVT-802 and is a key step in ongoing efforts to support an FDA filing. RVT-802 is an investigational, thymic-tissue based regenerative therapy